Parkinson Study Group
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Neptune Rd 420, Boston, Massachusetts,...Phone Number
(585) 275-1642Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Parkinson Study Group
The Parkinson Study Group (PSG) is the largest non-profit clinical trial site network in North America dedicated to advancing research on Parkinson's disease. Comprising over 155 sites and more than 375 credentialed investigators, PSG facilitates collaborative research and innovation in the field. The organization seeks to expand its clinical trial sites and is committed to partnering with trained investigators experienced in Parkinson's disease studies. PSG also offers mentorship initiatives and resources to support its members and enhance research capabilities.Explore more
Popular SearchesParkinson Study GroupParkinson Study Group IncSIC Code 87,873NAICS Code 54,541Show moreParkinson Study Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Parkinson Study Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Parkinson Study Group launches new products
Funding: Get notified immidiatlly once Parkinson Study Group has new funding data
Congratulate Masked Content for being promoted to Masked Content at Parkinson Study Group
Earning: See what the market has to say on Parkinson Study Group recently announced quarterly report
Check out if Parkinson Study Group is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Parkinson Study Group has recently received funding, and reach out quickly before it becomes old news!
Click to see if Parkinson Study Group had a recent Job posting/layoffs
Parkinson Study Group, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Parkinson Study Group as Masked Content
Find more new buyers
Compare Similar Companies to Parkinson Study Group
Compare insights from companies similar to Parkinson Study Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Parkinson Study Group is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Parkinson Study Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Parkinson Study Group.
Parkinson Study Group financials insights
Gather financial insights about Parkinson Study Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Other Financing Round
$115M
Parkinson Study Group Tech Stack
A closer look at the technologies used by Parkinson Study Group
Parkinson Study Group News & Media
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual MeetingMitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group
JERSEY CITY, N.J., Dec. 4, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of two abstracts on investigational ND0612 in Parkinson's disease (PD) at the 2024 Annual Meeting of the Parkinson Study Group (PSG), being held December 5-8 in...Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, announced that it has partnered with the Parkinson Study Group (PSG) to form an Advisory Board to leverage the group’s expertise and further develop the company’s Parkinson’s disease (PD) program. In addition, Cortexyme will present new data further demonstrating the role of Porphyromonas gingivalis (P. gingivalis) in th
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Parkinson Study Group
Sign Up For FreeTo access detailed company insights
The Parkinson Study Group (PSG) is the largest non-profit clinical trial site network in North America dedicated to advancing research on Parkinson's disease. Comprising over 155 sites and more than 375 credentialed investigators, PSG facilitates collaborative research and innovation in the field. The organization seeks to expand its clinical trial... Read More
